Modulating Glycolysis to Improve Cancer Therapy

Area of Science:

• Oncology
• Cancer Metabolism

Background:

• Cancer cells exhibit metabolic reprogramming, favoring glycolysis (Warburg effect) for survival and proliferation.
• This enhanced glycolysis provides a survival advantage and contributes to chemo/radioresistance.
• Immune cells in the tumor microenvironment also adopt a glycolytic profile, leading to nutrient competition.

Purpose of the Study:

• To review the role of metabolic reprogramming in cancer cells.
• To explore targeting cancer cell glycolysis as a strategy to enhance conventional cancer therapy efficacy.

Main Methods:

• Literature review of current understanding of cancer cell metabolic reprogramming.
• Analysis of studies investigating targeting glycolysis in cancer treatment.

Main Results:

• Enhanced glycolysis is a hallmark of cancer, supporting tumor growth and treatment resistance.
• Targeting cancer cell glycolysis shows potential to sensitize cancer cells to various therapies.
• Current strategies for targeting glycolysis are in pre-clinical and clinical evaluation.

Conclusions:

• Metabolic reprogramming, specifically enhanced glycolysis, is crucial for cancer cell survival and therapeutic resistance.
• Targeting cancer cell glycolysis represents a promising therapeutic strategy to improve conventional cancer treatment outcomes.
• Further development of effective and specific strategies to target cancer cell glycolysis is needed.